The Antibody Series 2023
The 3rd edition of The Antibody Series took place in the stunning Vidago Palace, a spa city in Portugal. The 2023 scientific agenda was composed by Dennis Burton, Professor at The Scripps Institute and included special Keynotes and topics on Antibody Multivalency, Computation and AI, Novel Antibodies and Antibodies and Immunity.
![](https://antibodyseries.com/wp-content/uploads/2024/05/dennis-TAS23.jpg)
Gallery
2023 Speakers
![](https://antibodyseries.com/wp-content/uploads/2024/05/Untitled-design-48.png)
MIT, ASSISTANT PROFESSOR
![](https://antibodyseries.com/wp-content/uploads/2024/05/Untitled-design-48.png)
SCRIPPS RESEARCH, ASSOCIATE PROFESSOR
![](https://antibodyseries.com/wp-content/uploads/2024/05/Untitled-design-48.png)
MODEX THERAPEUTICS, CO-FOUNDER, PRESIDENT AND CEO
![](https://antibodyseries.com/wp-content/uploads/2024/05/Untitled-design-48.png)
UTRECHT UNIVERSITY, PROFESSOR, PI AND HEAD OF IMMUNOGLOBULIN RESEARCHAT SANQUIN RESEARCH
![](https://antibodyseries.com/wp-content/uploads/2024/05/Untitled-design-48.png)
ARGENX, CO-FOUNDER
![](https://antibodyseries.com/wp-content/uploads/2024/05/Untitled-design-48.png)
ALCHEMAB THERAPEUTICS, CSO
![](https://antibodyseries.com/wp-content/uploads/2024/05/Untitled-design-48.png)
OREGON HEALTH & SCIENCE UNIVERSITY, PROFESSOR
![](https://antibodyseries.com/wp-content/uploads/2024/05/Untitled-design-48.png)
LUMC, ASSOCIATE PROFESSOR AND GROUP LEADER, DEPARTMENT OF HUMAN GENETICS AND DEPARTMENT OF NEUROLOGY
![](https://antibodyseries.com/wp-content/uploads/2024/05/Untitled-design-48.png)
TAVOTEK BIOTHERAPEUTICS, CSO
![](https://antibodyseries.com/wp-content/uploads/2024/05/Untitled-design-48.png)
EMBL-EBI, HEAD OF MACROMOLECULES, STRUCTURE, CHEMISTRY AND BIOIMAGING
![](https://antibodyseries.com/wp-content/uploads/2024/05/Untitled-design-48.png)
GV20 THERAPEUTICS, CO-FOUNDER & CEO
![](https://antibodyseries.com/wp-content/uploads/2024/05/Untitled-design-48.png)
DIRECTOR, RESEARCH AND DISCOVERY
![](https://antibodyseries.com/wp-content/uploads/2024/05/Untitled-design-48.png)
CHUGAI PHARMACEUTICAL CO., HEAD OF TRANSLATIONAL RESEACH DIVISION
![](https://antibodyseries.com/wp-content/uploads/2024/05/Untitled-design-48.png)
UNIVERSITY OF OSLO, ASSOCIATE PROFESSOR FOR SYSTEMS IMMUNOLOGY